MRI detection of hypointense brain lesions in patients with multiple sclerosis: T1 spin-echo vs. gradient-echo  by Dupuy, Sheena L. et al.
M
s
S
S
a
B
b
c
a
A
R
R
A
K
M
M
T
T
H
1
e
a
d
i
r
H
m
i
P
h
0
lEuropean Journal of Radiology 84 (2015) 1564–1568
Contents lists available at ScienceDirect
European  Journal  of  Radiology
j ourna l h o mepage: www.elsev ier .com/ locate /e j rad
RI  detection  of  hypointense  brain  lesions  in  patients  with  multiple
clerosis:  T1  spin-echo  vs.  gradient-echo
heena  L.  Dupuya,  Shahamat  Tauhida, Gloria  Kima,  Renxin  Chua, Subhash  Tummalaa,
helley  Hurwitzc,  Rohit  Bakshia,b,∗
Departments of Neurology, Brigham and Women’s Hospital, Laboratory for Neuroimaging Research, Partners MS  Center, Harvard Medical School,
oston, MA,  USA
Departments of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Departments of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 4 February 2015
eceived in revised form 20 April 2015
ccepted 5 May  2015
eywords:
ultiple sclerosis
RI
1 gradient-echo
1 spin-echo
ypointense lesions
a  b  s  t  r  a  c  t
Objective:  Compare  T1  spin-echo  (T1SE)  and T1  gradient-echo  (T1GE)  sequences  in  detecting  hypointense
brain  lesions  in  multiple  sclerosis  (MS).
Background:  Chronic  hypointense  lesions  on T1SE  MRI  scans  are a surrogate  of  severe  demyelination  and
axonal  loss in  MS.  The  role of  T1GE  images  in the  detection  of  such  lesions  has not been  clariﬁed.
Design/methods:  In 45 patients  with  MS  [Expanded  Disability  Status  Scale  (EDSS)  score (mean  ± SD)
3.5  ± 2.0;  37  relapsing-remitting  (RR);  8 secondary  progressive  (SP)],  cerebral  T1SE,  T1GE,  and  T2-
weighted  ﬂuid-attenuated  inversion-recovery  (FLAIR)  images  were  acquired  on a 1.5  T  MRI  scanner.
Images  were  re-sampled  to axial  5 mm  slices  before  directly  comparing  lesion  detectability  using Jim
(v.7,  Xinapse  Systems).  Statistical  methods  included  Wilcoxon  signed  rank  tests  to  compare  sequences
and  Spearman  correlations  to test  associations.
Results: Considering  the  entire  cohort,  T1GE  detected  a higher  lesion  volume  (5.90  ± 6.21  vs.
4.17  ±  4.84  ml,  p  <  0.0001)  and  higher  lesion  number  (27.82  ±  20.66  vs. 25.20  ±  20.43, p  < 0.05)  than  T1SE.
Lesion  volume  differences  persisted  when  considering  RR  and  SP patients  separately  (both  p <  0.01).
A  higher  lesion  number  by T1GE  was  seen  only  in the  RR  group  (p < 0.05).  When  comparing  correla-
tions  between  lesion  volume  and overall  neurologic  disability  (EDSS  score),  T1SE  correlated  with EDSS
(Spearman  r = 0.29,  p  < 0.05)  while  T1GE  (r  =  0.23,  p =  0.13) and  FLAIR  (r =  0.24,  p  = 0.12)  did not.
Conclusion:  Our  data  suggest  that  hypointense  lesions  on  T1SE  and  T1GE  are  not interchangeable  in
patients  with  MS.  Based  on these  results,  we  hypothesize  that  T1GE  shows  more  sensitivity  to  lesions  at
the  expense  of less  pathologic  speciﬁcity  for tissue  destruction  than  T1SE.
rs.  Pu©  2015  The  Autho
. Introduction
Multiple sclerosis (MS) is an inﬂammatory demyelinating dis-
ase of the CNS, characterized by lesions and atrophy of the brain
nd spinal cord. MRI  techniques have been the key in deﬁning
isease pathology and severity [1]. T1-weighted spin-echo (T1SE)
mages may  show chronic hypointense lesions, which are known to
epresent severe/irreversible demyelination with axonal loss [1–6].
owever, T1-weighted gradient-echo (T1GE) sequences also com-
only show hypointense lesions in patients with MS  [7]. Such
mages have an increasing role in both research and clinical settings
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with the growing use of 3 T scanners [1,8,9]. While the underlying
pathologic substrate of chronic hypointense MS  lesions on T1SE
scans has been determined [3], there are no similar studies to date
assessing the pathologic speciﬁcity of such lesions on T1GE scans.
In this study, we  compared T1SE and T1GE sequences side-by-side
in patients with MS  to clarify to what extent hypointense lesions
are interchangeable between the two  pulse sequences.
2. Methods
2.1. SubjectsSubjects’ demographic and clinical data are summarized in
Table 1. We  studied 45 consecutive patients with MS,  all of
which were assessed by a neurologist within one week of MRI  for
 access article under the CC BY-NC-ND license (http://creativecommons.org/
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Table  1
Demographics and clinical data.
Patients with MS  (n) n = 45
Age  (years) 42.3 ± 8.3 (23–59)
Women n = 33 (73%)
Men  n = 12 (27%)
Disease category
Relapsing-remitting n = 37 (82%)
Secondary progressive n = 8 (18%)
Disease duration 11.0 ± 7.8 (1–38)
EDSS score 3.5 ± 2.0 (1–8)
T25FW 13.3 ± 29.5 (4–170 )
Key: mean ± standard deviation (range); MS,  multiple sclerosis; disease dura-
tion (years), years since ﬁrst symptoms; EDSS, Expanded Disability Status Scale;
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3.3. Correlation between MRI and neurologic function
Among all MRI  lesion measures, only T1SE lesion volume
showed signiﬁcant correlations with clinical status (Table 3). T1SE
Table 2
Hypointense lesion volume and number: T1SE vs. T1GE.
FLAIR 2D T1
spin-echo
3D T1
gradient-echo
p (T1SE vs.
T1GE)
Lesion vol. (ml)
All patients 12.9 ± 13.2 4.2 ± 4.8 5.9 ± 6.2 <0.0001*
RR 10.7 ± 10.0 3.2 ± 3.5 4.9 ± 5.1 <0.0001*
SP 23.1 ± 20.7 8.5 ± 7.7 10.6 ± 8.9 0.008*
p (RR vs. SP) 0.11 0.04* 0.08
Lesion number
All patients – 25.2 ± 20.4 27.8 ± 20.7 0.02*
RR – 21.7 ± 17.8 25.0 ± 19.0 0.01*
SP – 41.3 ± 25.3 41.1 ± 24.1 0.98
p  (RR vs. SP) – 0.03* 0.06
Key: data are mean ± standard deviation; total cerebral hypointense lesion volume
and number are shown; FLAIR, ﬂuid-attenuated inversion-recovery; RR, relapsing-25FW(s), timed 25 foot walk.
isability by the Expanded Disability Status Scale (EDSS) and timed
5-foot walk.
.2. Image acquisition
All patients underwent brain MRI  on the same scanner (1.5 T
yroscan ACS-NT; Phillips, Best, the Netherlands) using the same
cquisition protocol, including 2D T1-weighted spin-echo (T1SE),
D T1-weighted gradient-echo (T1GE), and 2D T2-weighted ﬂuid-
ttenuated inversion-recovery (FLAIR). Only non-contrast images
ere available; the patients did not receive intravenous gadolin-
um. T1SE images had a voxel size = 0.89 mm × 0.89 mm × 5 mm,
R = 400 ms,  TE = 10 ms,  24 gapless axial slices. T1GE had
 voxel size = 0.98 mm × 0.98 mm × 2.5 mm,  TR = 24 ms,
E = 7 ms,  70 gapless coronal slices. FLAIR images had a voxel
ize = 0.94 mm  × 0.94 mm × 5 mm,  TR = 8000 ms,  TE = 120 ms,
nversion time = 2200 ms,  24 gapless axial slices.
.3. MRI  analysis
Lesions on each of the FLAIR, T1SE, and T1GE images were ﬁrst
arked by a trained observer (SD). These were veriﬁed by a senior
bserver (ST). All three images were reviewed concurrently. The
rained observer then measured whole brain lesion volumes from
ll three images by a semi-automated edge-ﬁnding tool using Jim
v.7, Xinapse Systems, West Bergholt, UK; www.xinapse.com), as
reviously described [10]. It was not possible for the raters to be
linded to the type of T1-weighted MRI  sequence because T1SE
nd T1GE images had distinct differences in their tissue contrast. A
ypointensity on T1SE or T1GE images was only classiﬁed as a lesion
f it also showed at least partial hyperintensity on FLAIR images, a
equirement that was applied to avoid the inclusion of benign cysts
r enlarged perivascular spaces as MS  lesions. In addition, whole
rain lesion number was  measured for T1SE and T1GE images.
Given the differences in native orientation and resolution
etween the T1SE and T1GE images, the latter were re-sampled to
atch T1SE images (and approximate the FLAIR images) in orien-
ation and voxel size using Jim. The primary analysis in all subjects
as performed using native T1SE, re-sampled T1GE, and native
LAIR images.
To assess whether image resampling alone would have any
ffect on the diagnostic yield, we performed a sub-study of 10 ran-
omly chosen T1SE scans. The two image sets were matched on
oxel size and axial orientation. The Pearson correlation between
otal cerebral lesion volume obtained from native vs. re-sampled
as an r = 0.99, indicating very high agreement; therefore, we
resent the full cohort data obtained from the native T1SE images.
ample images are shown in Fig. 1.adiology 84 (2015) 1564–1568 1565
2.4. Statistical analysis
T1SE and T1GE derived lesion volumes and lesion numbers
were compared in all patients and between patient subgroups with
Wilcoxon tests. Spearman or Pearson correlations were used to
assess MRI  vs. clinical and MRI  vs. MRI  relationships. A p < 0.05 was
considered signiﬁcant.
3. Results
3.1. T1SE vs. T1GE derived lesion volumes and lesion numbers
Considering the entire cohort, a high correlation was seen
between T1SE and T1GE when comparing both lesion vol-
ume  (Spearman r = 0.98, p < 0.0001) and lesion number (r = 0.94,
p < 0.0001) as depicted in Fig. 2.
Signiﬁcant differences were seen when comparing T1SE derived
lesion measures to T1GE (Table 2, Figs. 1–3). When consider-
ing all subjects, T1GE detected a higher lesion volume than
T1SE [(mean ± SD) 5.90 ± 6.21 vs. 4.17 ± 4.84 ml,  p < 0.0001]. When
assessing the RR and SP patient subgroups separately, the signiﬁ-
cant lesion volume differences persisted. In the RR subgroup, T1GE
derived lesion volumes were signiﬁcantly higher than T1SE meas-
ures (4.87 ± 5.05 vs. 3.22 ± 3.49, p < 0.0001). The same was observed
in the SP patient subgroup (10.64 ± 8.94 vs. 8.52 ± 7.65, p = 0.008).
Similarly, when considering the entire cohort, T1GE derived
lesion numbers were signiﬁcantly higher than T1SE (27.82 ± 20.66
vs. 25.20 ± 20.43, p = 0.02). These lesion number differences were
also observed in the RR patient subgroup (24.95 ± 18.98 vs.
21.73 ± 17.79, p = 0.01). However, the difference did not persist in
the SP patient subgroup; T1GE and T1SE derived measures were not
signiﬁcantly different (41.13 ± 24.14 vs. 41.25 ± 25.25, p = 0.98).
3.2. RR vs. SP patient subgroups
As shown in Table 2, when comparing RR and SP patient groups,
SP patients had a signiﬁcantly higher T1SE lesion volume (p = 0.04)
and lesion number (p = 0.03) than RR patients; however, this was
not seen on T1GE scans (both p > 0.05). The aforementioned dif-
ferences were not robust in that RR and SP patients were not
signiﬁcantly different in terms of their T1GE and T1SE method dis-
parities (volume and number both p > 0.35.)remitting MS; SP, secondary progressive MS;  FLAIR lesion number was not assessed;
vol., volume.
* p < 0.05.
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Fig. 1. MRI  scans from a patient showing the higher sensitivity of T1GE vs. T1SE in detecting a multiple sclerosis (MS) white matter lesion. This is a 45 year-old woman
with  relapsing-remitting MS  of 11 years disease duration and mild physical disability (Expanded Disability Status Scale score = 2.5; Timed 25 foot walk = 5.7 s). The white
arrows show a lesion detected by FLAIR and T1GE but not T1SE. The patient’s whole brain lesion volume was: FLAIR = 15.9 ml, T1SE = 4.1 ml, T1GE = 4.8 ml.  Note: FLAIR,
ﬂuid-attenuated inversion-recovery; T1SE, T1 spin-echo; T1GE, T1 gradient-echo. Resampled T1SE and T1GE images are shown.
Fig. 2. Cerebral hypointense lesion volume and number in 45 patients with multiple sclerosis: T1SE vs. T1GE. A high correlation was seen between T1SE and TIGE when
comparing both total cerebral volume and number of lesions. Note: T1SE, T1 spin-echo; T1GE, T1 gradient-echo; vol., total cerebral volume (ml); num, total cerebral number
of  lesions; small circles indicate individual subjects; large circles represent means.
Fig. 3. MRI  scans from a patient showing the higher sensitivity of T1GE vs. T1SE in detecting juxtacortical/cortical multiple sclerosis (MS) lesions. The upper panel shows
the  native images. The lower panel shows zoomed and cropped images to illustrate the key ﬁndings. This is a 45 year-old woman with relapsing-remitting MS of 13 years
disease  duration and mild physical disability (Expanded Disability Status Scale score = 1.5; Timed 25 foot walk = 6.0 s). The white arrows show lesions detected by FLAIR and
T1GE  but not T1SE. The patient’s whole brain lesion volume was: FLAIR = 38.3 ml,  T1SE = 12.5 ml,  T1GE = 16.2 ml.  Note: FLAIR, ﬂuid-attenuated inversion-recovery; T1SE, T1
spin-echo; T1GE, T1 gradient-echo. Resampled T1SE and T1GE images are shown.
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Table  3
Correlation between lesions and clinical status.
EDSS score
(n = 45)
Disease duration
(n = 45)
T25FW (n = 38)
rs p rs p rs p
T1SE lesion vol. 0.299 0.046* 0.194 0.202 0.320 0.050
T1GE lesion vol. 0.231 0.127 0.153 0.316 0.250 0.130
T1SE lesion # 0.210 0.166 0.215 0.156 0.225 0.175
T1GE lesion # 0.193 0.204 0.079 0.606 0.113 0.498
FLAIR lesion vol. 0.237 0.116 0.153 0.315 0.243 0.141
Key: rs, Spearman correlation coefﬁcient; T1SE, T1 spin-echo; T1GE, T1 gradient-
echo; vol., volume; FLAIR, ﬂuid-attenuated inversion-recovery; EDSS, Expanded
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[isability Status Scale; T25FW = timed 25 foot walk.
* p < 0.05.
orrelated signiﬁcantly with EDSS score (r = 0.299, p < 0.05), while
1GE (r = 0.231, p = 0.127) and FLAIR (r = 0.237, p = 0.116) did not.
n addition to EDSS score, correlations between lesion volume and
isease duration and timed 25-foot walk were compared; however,
o signiﬁcant associations were found (Table 3).
. Discussion
The purpose of this study was to clarify the role of a T1GE
equence in MS  cerebral hypointense lesion detection by direct
omparison to a conventional T1SE sequence. The results indicate,
rom several perspectives, that T1GE images show more sensitivity
han T1SE. This included the detection of both a signiﬁcantly
igher lesion number and total cerebral lesion volume than T1SE.
urthermore, the increased sensitivity to a higher lesion volume
as broadly present in the cohort, continuing to persist when sep-
rately considering the RR and SP patient subgroups. However, the
igniﬁcant increase in lesion number detection by T1GE vs. T1SE
cans was not seen in the SP subgroup. This comparison may  have
een under-powered due to the small sample size in the SP group.
lternatively, this may  relate to the change in biologic dynamics
s patients progress from the RR to SP phase of the disease. As
isability increases, patients are known to experience a plateauing
f adaptive immunity-related new inﬂammatory events and are
hus less likely to form new lesions [11,12]. However, the lesion
oad may  continue to slowly increase due to innate immunity-
ediated chronic inﬂammation and Wallerian degeneration [12].
he T1GE and T1SE images were obtained on the same scanner at
he same time and were matched on voxel size/resolution. Thus
he higher sensitivity is likely intrinsic to the T1GE pulse sequence
wing to technical factors such as improved tissue contrast [13].
We also assessed the validity of the two sequences, deﬁned
s the relationships between MRI  ﬁndings and clinical status. The
ndings of this study suggest that T1SE images show a closer rela-
ionship to disease severity than T1GE. This higher validity of T1SE
as seen in several ways. First, when comparing RR to SP patients,
 signiﬁcantly higher lesion volume was shown in SP patients on
1SE but not T1GE images. Second, when comparing MRI ﬁndings
o the level of neurologic function, only T1SE-deﬁned lesion load
howed a signiﬁcant (albeit weak-to-moderate) correlation with
DSS score, a relationship that has been shown by several previous
tudies [1–3,5,14]. Thus, we hypothesize that the lesions shown
n T1GE are less speciﬁc for destructive irreversible changes (e.g.
evere demyelination, axonal loss) than T1SE. Such lesions on T1GE
mages may  instead represent a wide range of pathologic features,
ome of which are mild and potentially reversible (e.g. inﬂamma-
ion, edema, gliosis, partial demyelination). Such non-speciﬁcity
ould be analogous to what has been reported within T2 hyperin-
ense MS  lesions, which also show weaker relationships to clinical
tatus than T1SE-deﬁned hypointense lesions [2,4,15].
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Our study suggests that T1GE and T1SE derived lesions meas-
ures are not interchangeable. The T1SE sequence appears to be
less sensitive but more speciﬁc in detecting focal lesions with
severe tissue damage compared to the T1GE sequence. Nonethe-
less, our study does not discount the continuing important role of
T1GE images in MS  research. Such images provide a range of bene-
ﬁts compared to conventional SE sequences such as the improved
detectability of cortical lesions and the improved suitability of these
images for ﬁne structure deﬁnition and morphometric segmenta-
tions [7,13,16–20].
There are limitations of our study worthy of comment. We  per-
formed this study with low resolution images on a 1.5 T scanner at
one time point, with a limited sample size. Given the small size of
the SPMS subgroup, the RR vs. SP comparisons should be viewed
as pilot data representing preliminary results. In addition, a possi-
ble bias was  present due to the inability to blind the observers to
image type. Furthermore, the native resolution differences between
the T1SE and T1GE images may  have introduced inherent partial
volume averaging differences despite the resampling of the data
sets. Future studies should longitudinally assess any differences at
higher ﬁeld strength (e.g. 3 T) platforms with 3D high resolution
data sets. In addition, it would be interesting to extend our results
by performing histological analysis in order to verify whether T1GE
images do in fact show less pathologic speciﬁcity for destructive
lesions than T1SE images.
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